Top-quality diagnostic imaging and metabolic therapy treatments, with the care you deserve.
ATRYS-SIMM is a diagnostic imaging and curative and palliative metabolic therapy company belonging to SIMM Molecular, S.L.U., staffed by specialist physicians who are pioneers in Nuclear Medicine. Our equipment features the latest technological innovations and we use cutting-edge Nuclear Medicine protocols.
We have two service centres, ATRYS-SIMM IRLA and ATRYS-SIMM SJD. At both, we put patient care first and offer diagnostic techniques and therapies to reach the best possible diagnosis and treatment, safely and quickly. To achieve the highest possible standard of care, we take part in multidisciplinary committees, clinical conferences and national and international medical congresses.
SIMM Molecular, S.L.U. is part of the ATRYS Health group. For more information, visit atryshealth.com.
Our Quality Policy is founded on the satisfaction of our patients and the speed and accuracy of our services, with a dynamic, feedback-driven quality system that combines technology with a highly qualified team committed to continuous training. Read our full Quality Policy and our Environmental Policy.
Mission
Performing diagnostic imaging examinations and delivering metabolic therapy treatments, using the most innovative drugs and the latest technologies, while treating our patients with the utmost care and humanity.
Vision
To be a reference unit in Spain and across Europe in the specialty of Nuclear Medicine, through our quality of care and our focus on research, placing patients at the centre of all our efforts.
Values
Our medical team includes internationally renowned specialists in clinical practice and research. We comply with radiation protection legislation and hold the official permits and accreditations for radioactive medical facilities.
We process your personal data in accordance with the GDPR and Spanish data protection legislation. See full details in our Privacy Policy.
Information about the website owner, terms of use and intellectual property. Read the full Legal Notice.
Diagnostic tests and metabolic therapies in oncology, cardiology, neurology and much more, with the most advanced PET-CT and SPECT-CT technology.
Diagnostic and follow-up tests for disorders of the circulatory system: vasculitis, haemangiomas, and lymphatic and vascular studies.
View full details →
Assessment of myocardial perfusion and function, coronary artery disease, ischaemia and necrosis, and prosthetic and vascular infection.
View full details →
Use of radiation-detection probes during surgery to locate and remove tissue previously labelled with a radiopharmaceutical.
View full details →
Precise measurement of bone mineral density to determine fracture risk, osteoporosis and the progression of calcium loss.
View full details →
Diagnosis and therapy in the field of Endocrinology: detection and measurement of endocrine glands and radionuclide treatment.
View full details →
Studies of the digestive system using physiological imaging and non-invasive techniques.
View full details →Detection of infectious and inflammatory processes using biological markers, essential for planning therapeutic decisions.
View full details →
Non-invasive assessment of renal function: pyelonephritis, obstructive uropathy, kidney transplantation and cortical abnormalities.
View full details →
Study of pulmonary perfusion and ventilation, particularly in the diagnosis of pulmonary thromboembolism.
View full details →
Diagnosis of dementias, vascular disorders, epilepsies and diseases affecting neurotransmitters, such as Parkinson's disease.
View full details →
Dacryocystography to study the lacrimal apparatus and detect tear duct obstructions.
View full details →
Detection and staging of cancer, its recurrence, treatment response and follow-up using PET-CT.
View full details →
Detection of osteoporosis, primary bone cancer, bone metastases, osteoarthritis, arthritis, and sports and trauma injuries.
View full details →
Metabolic and anatomical body imaging combining computed tomography and positron emission tomography in a single hybrid scanner.
View full details →
Use of radiopharmaceuticals to treat thyroid disease, neuroendocrine tumours and metastatic bone pain, as well as radioembolisation and radiosynoviorthesis.
View full details →
The new digital PET-CT scanner features an extended 30 cm detection field, twice that of conventional scanners, reducing scan time and radiation dose by up to 50%.
Read full story →
Theranostics in paediatric oncology represents a pioneering clinical advance in Spain and Europe, offering maximum efficacy against tumour cells with minimal impact on healthy tissue.
View full details →
ATRYS Health and Hospital Sant Joan de Déu in Barcelona open the Nuclear Medicine service at the hospital's ATRYS-SIMM SJD Centre, through ATRYS's subsidiary SIMM Molecular.
Read full story →
ATRYS-SIMM opened its new service at the PCCB of Hospital Sant Joan de Déu, with state-of-the-art equipment and facilities and a specialisation in developmental tumours.
View full details →
An agreement with the internationally renowned maternal and child health hospital to manage the nuclear medicine area of the future SJD Pediatric Cancer Center.
View full details →
ATRYS Health announces the acquisition of 100% of SIMM Molecular, S.L., a European leader in nuclear medicine and molecular and metabolic diagnostic imaging.
Read full story →Write to us, call us or visit us at either of our two centres in Barcelona.
Carrer Josep Irla i Bosch, 5, Building 2, Ground floor
Barcelona 08034, Catalonia, Spain
Telephone: (+34) 93 204 6439 · Fax: (+34) 93 204 9641
Carrer Santa Rosa, 39, Pediatric Cancer Center Barcelona
Esplugues de Llobregat 08950, Catalonia, Spain
Telephone: (+34) 93 254 0470
You can also write to us using the form or use the ATRYS Communications Channel (also available in Spanish and Portuguese), which guarantees the confidentiality of your identity.